BACKGROUND: Lutein and zeaxanthin are thought to have beneficial effects on protecting the lens against cataract formation, but findings from epidemiologic studies have been inconsistent. We aimed to conduct a meta-analysis of prospective cohort studies to examine the association between dietary lutein and zeaxanthin intake and risk of age-related cataract (ARC). METHODS: We systematically searched MEDLINE, EMBASE, Web of Science, and Cochrane Library databases up to March 2013. Reference lists from retrieved articles were also reviewed. The adjusted relative risks (RRs) from each study were extracted to calculate a pooled estimate with its 95 % confidence interval (CI). The dose-response relationships were assessed by using generalized least-squares trend estimation. RESULTS: Six prospective cohort studies were identified involving 4,416 cases and 41,999 participants. For the comparison between the highest and the lowest categories of dietary lutein and zeaxanthin intake, significant inverse association were found for nuclear cataract (RR: 0.75; 95 % CI: 0.65, 0.85), but not for cortical cataract (RR: 0.85; 95 % CI: 0.53, 1.17) and for posterior subcapsular cataract (RR: 0.77; 95 % CI: 0.40, 1.13). Dose-response analysis showed that every 300 μg/d increment in dietary lutein and zeaxanthin intake was associated with a 3 %, 1 %, or 3 % reduction in the risk of nuclear cataract (RR: 0.97; 95 % CI: 0.94, 0.99), cortical cataract (RR: 0.99; 95 % CI: 0.95, 1.02), or posterior subcapsular cataract (RR: 0.97; 95 % CI: 0.93, 1.01) respectively. CONCLUSIONS: Dietary lutein and zeaxanthin intake is associated with a reduced risk of ARC, especially nuclear cataract in a dose-response manner, indicating a beneficial effect of lutein and zeaxanthin in ARC prevention.
BACKGROUND: Lutein and zeaxanthin are thought to have beneficial effects on protecting the lens against cataract formation, but findings from epidemiologic studies have been inconsistent. We aimed to conduct a meta-analysis of prospective cohort studies to examine the association between dietary lutein and zeaxanthin intake and risk of age-related cataract (ARC). METHODS: We systematically searched MEDLINE, EMBASE, Web of Science, and Cochrane Library databases up to March 2013. Reference lists from retrieved articles were also reviewed. The adjusted relative risks (RRs) from each study were extracted to calculate a pooled estimate with its 95 % confidence interval (CI). The dose-response relationships were assessed by using generalized least-squares trend estimation. RESULTS: Six prospective cohort studies were identified involving 4,416 cases and 41,999 participants. For the comparison between the highest and the lowest categories of dietary lutein and zeaxanthin intake, significant inverse association were found for nuclear cataract (RR: 0.75; 95 % CI: 0.65, 0.85), but not for cortical cataract (RR: 0.85; 95 % CI: 0.53, 1.17) and for posterior subcapsular cataract (RR: 0.77; 95 % CI: 0.40, 1.13). Dose-response analysis showed that every 300 μg/d increment in dietary lutein and zeaxanthin intake was associated with a 3 %, 1 %, or 3 % reduction in the risk of nuclear cataract (RR: 0.97; 95 % CI: 0.94, 0.99), cortical cataract (RR: 0.99; 95 % CI: 0.95, 1.02), or posterior subcapsular cataract (RR: 0.97; 95 % CI: 0.93, 1.01) respectively. CONCLUSIONS: Dietary lutein and zeaxanthin intake is associated with a reduced risk of ARC, especially nuclear cataract in a dose-response manner, indicating a beneficial effect of lutein and zeaxanthin in ARC prevention.
Authors: Hien T V Vu; Luba Robman; Allison Hodge; Catherine A McCarty; Hugh R Taylor Journal: Invest Ophthalmol Vis Sci Date: 2006-09 Impact factor: 4.799
Authors: David C Beebe; Nancy M Holekamp; Carla Siegfried; Ying-Bo Shui Journal: Philos Trans R Soc Lond B Biol Sci Date: 2011-04-27 Impact factor: 6.237
Authors: Redmer van Leeuwen; Sharmila Boekhoorn; Johannes R Vingerling; Jacqueline C M Witteman; Caroline C W Klaver; Albert Hofman; Paulus T V M de Jong Journal: JAMA Date: 2005-12-28 Impact factor: 56.272
Authors: Haleh Ghaem Maralani; Bee Choo Tai; Tien Y Wong; E Shyong Tai; Jialiang Li; Jie Jin Wang; Paul Mitchell Journal: Invest Ophthalmol Vis Sci Date: 2013-01-21 Impact factor: 4.799
Authors: Nathan Congdon; Johannes R Vingerling; Barbara E K Klein; Sheila West; David S Friedman; John Kempen; Benita O'Colmain; Suh-Yuh Wu; Hugh R Taylor Journal: Arch Ophthalmol Date: 2004-04
Authors: Suzen M Moeller; Rick Voland; Lesley Tinker; Barbara A Blodi; Michael L Klein; Karen M Gehrs; Elizabeth J Johnson; D Max Snodderly; Robert B Wallace; Richard J Chappell; Niyati Parekh; Cheryl Ritenbaugh; Julie A Mares Journal: Arch Ophthalmol Date: 2008-03
Authors: Hong Jiang; Li-Na Wang; Yan Liu; Ming Li; Min Wu; Yue Yin; Le Ma; Chang-Rui Wu Journal: Int J Ophthalmol Date: 2020-04-18 Impact factor: 1.779
Authors: Katherine M Ranard; Sookyoung Jeon; Emily S Mohn; James C Griffiths; Elizabeth J Johnson; John W Erdman Journal: Eur J Nutr Date: 2017-12 Impact factor: 5.614
Authors: Alfredo García-Layana; Gianfranco Ciufo; Estefania Toledo; Miguel A Martínez-González; Dolores Corella; Montse Fitó; Ramon Estruch; Enrique Gómez-Gracia; Miguel Fiol; José Lapetra; Lluís Serra-Majem; Xavier Pintó; Maria P Portillo; José V Sorli; Mónica Bulló; Ernest Vinyoles; Aleix Sala-Vila; Emilio Ros; Jordi Salas-Salvadó; Fernando Arós Journal: Nutrients Date: 2017-05-03 Impact factor: 5.717